Inspection Record

Aurorium LLC — FDA 483 Findings

US FDAInspected 2026-03-06Published 2026-07-10 4 findingsLaboratory and QC controlsQuality unit oversightOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Laboratory and QC controls

Failure to perform testing of the (b) (4) used in production and in the QC Laboratory.

2Quality unit oversight

Failure of the Quality Unit to fulfill its oversight responsibilities.

3Other quality system

Failure to investigate all out of specification test results.

4Quality unit oversight

Your firm failed to conduct an annual product quality review of your API.

About this record

Extracted automatically from the document US FDA published on 2026-07-10. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Aurorium LLC company profile — full history US FDA documents, 2026 Go to Findings search